Faecal AbsoluteBiome™ is now ready for clinical and research use. Many microbiome tests report relative percentages only, which can be difficult to interpret for longitudinal monitoring as percentage shifts do not always reflect true changes in microbial load. AbsoluteBiome™ reports absolute measures alongside relative abundance, supporting clearer monitoring over time. Supported by CSIRO, we are now extending this innovation by applying advanced modelling to generate clinically relevant metrics and risk scores. This work will further strengthen clinical report utility.

This project was made possible by CSIRO Kick-Start, an initiative that provides funding and support for innovative Australian start-ups and SMEs to access CSIRO’s research expertise and capabilities to help grow and develop their business. csiro.au/kick-start/